Tag: Oncology

Absci collaborates with AstraZeneca for AI-designed oncology antibody

businessnewstoday- December 6, 2023

Absci Corporation (Nasdaq: ABSI), a leader in generative AI antibody discovery, announced a groundbreaking collaboration with AstraZeneca, a global biopharmaceutical company. This partnership aims to ... Read More

AbbVie to acquire ImmunoGen for $10.1bn to expand oncology portfolio

businessnewstoday- December 1, 2023

AbbVie Inc. and ImmunoGen Inc. have entered into a definitive agreement, marking a significant move in the pharmaceutical industry. AbbVie will acquire ImmunoGen, including its ... Read More

Perpetual Medicines secures $8m for peptide drug discovery platform

businessnewstoday- December 1, 2023

Perpetual Medicines, a frontrunner in computational peptide therapeutics, recently announced an impressive $8 million seed financing round, spearheaded by Chengwei Capital. This significant financial injection ... Read More

GSK’s DREAMM-7 trial shows promising results for Blenrep in multiple myeloma

businessnewstoday- November 28, 2023

GSK plc has unveiled positive outcomes from the DREAMM-7 head-to-head phase III trial, evaluating Blenrep (belantamab mafodotin) as a treatment for relapsed or refractory multiple ... Read More

Curium wraps up patient enrollment in ECLIPSE trial in prostate cancer

businessnewstoday- November 26, 2023

Curium, a leading figure in the global nuclear medicine sector, has proudly announced the successful completion of patient enrollment in the pivotal Phase 3 ECLIPSE ... Read More

Boehringer Ingelheim expands oncology portfolio with T3 Pharma acquisition

businessnewstoday- November 22, 2023

Boehringer Ingelheim announced its acquisition of T3 Pharmaceuticals AG (“T3 Pharma”), a Swiss biotech company specializing in immuno-oncology, for up to 450 million CHF. T3 ... Read More

FDA approves AstraZeneca’s Truqap for advanced breast cancer treatment

businessnewstoday- November 20, 2023

In a notable development in the field of oncology, the US Food and Drug Administration (FDA) has approved AstraZeneca’s Truqap (capivasertib) in combination with Faslodex ... Read More

ValiRx and StingRay Bio collaborate on preclinical cancer therapeutics research

businessnewstoday- November 10, 2023

ValiRx Plc (AIM: VAL), a pioneering life science company, has entered into a strategic agreement with StingRay Bio Limited to evaluate a series of drug ... Read More

Crown Bioscience launches OrganoidXplore: A game-changer for preclinical oncology research

businessnewstoday- November 8, 2023

Leading global contract research organization, Crown Bioscience, has unveiled OrganoidXplore, a trailblazing service offering in the domain of preclinical oncology research. This state-of-the-art platform promises ... Read More

Galapagos NV taps Landmark Bio for CAR-T therapy production

businessnewstoday- November 6, 2023

Landmark Bio has entered into a pivotal strategic manufacturing agreement with Galapagos NV, signaling a notable advance in the field of genomic medicines. This multi-year ... Read More